Inventor · Irmo, SC, US

Campbell McInnes

17Patents

5h-index

27Co-inventors

66Inventor score

Filing activity: May 19, 2003 → Feb 7, 2023

Most-cited inventions

Patent	Title	Area	Cited by	Status
US7432260B2	Pyrimidine compounds	Chemistry; Metallurgy	10	Expired
US7449544B2	p21 peptides	Human Necessities	9	Expired
US7897605B2	Pyrimidine compounds	Chemistry; Metallurgy	9	Active
US8566072B2	Cyclin based inhibitors of CDK2 and CDK4	Physics	8	Active
US7576091B2	Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases	Human Necessities	5	Expired
US9376465B2	Cyclin based inhibitors of CDK2 and CDK4	Human Necessities	4	Active
US10067131B2	Fragment ligated inhibitors selective for the polo box domain of PLK1	Physics	3	Active
US9328139B2	Cyclin based inhibitors of CDK2 and CDK4	Physics	3	Active
US9982015B2	Cyclin based inhibitors of CDK2 and CDK4	Human Necessities	3	Active
US11014906B2	Quinoline-based compounds and methods of inhibiting CDK8/19	Chemistry; Metallurgy	2	Active
US9175357B2	Fragment ligated inhibitors selective for the polo box domain of PLK1	Physics	2	Active
US11162083B2	Peptide based inhibitors of Raf kinase protein dimerization and kinase activity	Human Necessities	0	Active
US12415822B2	Small molecule inhibitors selective for polo-like kinase protein	Human Necessities	0	Active
US11712437B2	Inhibitors of lysyl oxidases	Chemistry; Metallurgy	0	Active
US11572369B2	Bicyclic pyridine compositions and methods of using the same for cancer therapy	Chemistry; Metallurgy	0	Active
US12281080B2	Quinoline-based compounds and methods of inhibiting CDK8/19	Chemistry; Metallurgy	0	Active
US11597737B2	Small molecule inhibitors selective for polo-like kinase proteins	Human Necessities	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.